BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9666572)

  • 1. Crystal structure of 180 degree K of bis-3, 5-diisopropylsalicylatobisdimethylsulfoxidozinc(II) and the inhibition of seizures and polymorphonuclear leukocyte chemiluminescence.
    Morgant G; Viossat B; Daran JC; Roch-Arveiller M; Giroud JP; Nguyen HD; Sorenson JR
    J Inorg Biochem; 1998 May; 70(2):137-43. PubMed ID: 9666572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-temperature crystal structures of tetrakis-mu-3,5-diisopropylsalicylatobis-dimethylformamidodico pper(II) and tetrakis-mu-3,5-diisopropylsalicylatobis-diethyletheratodicopp er(II) and their role in modulating polymorphonuclear leukocyte activity in overcoming seizures.
    Morgant G; Dung NH; Daran JC; Viossat B; Labouze X; Roch-Arveiller M; Greenaway FT; Cordes W; Sorenson JR
    J Inorg Biochem; 2000 Jul; 81(1-2):11-22. PubMed ID: 11001426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-temperature (180 K) crystal structure, electron paramagnetic resonance spectroscopy, and propitious anticonvulsant activities of CuII2(aspirinate)4(DMF)2 and other CuII2(aspirinate)4 chelates.
    Viossat B; Daran JC; Savouret G; Morgant G; Greenaway FT; Dung NH; Pham-Tran VA; Sorenson JR
    J Inorg Biochem; 2003 Aug; 96(2-3):375-85. PubMed ID: 12888273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, crystal structures, and anti-convulsant activities of ternary [Zn(II)(3,5-diisopropylsalicylate)(2)], [Zn(II)(salicylate)(2)] and [Zn(II)(aspirinate)(2)] complexes.
    Lemoine P; Viossat B; Dung NH; Tomas A; Morgant G; Greenaway FT; Sorenson JR
    J Inorg Biochem; 2004 Nov; 98(11):1734-49. PubMed ID: 15522401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copper(II) complexes of a nonsteroidal anti-inflammatory drug niflumic acid. Synthesis, crystal structure of tetrakis-mu-(2-[3-(trifluoromethyl) phenyl]aminonicotinato)bis(dimethylsulfoxide)-dicopper(II) complex at 190 K. Anti-inflammatory properties.
    Greenaway FT; Riviere E; Girerd JJ; Labouze X; Morgant G; Viossat B; Daran JC; Roch Arveiller M; Dung NH
    J Inorg Biochem; 1999 Jul; 76(1):19-27. PubMed ID: 10530003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, crystal structure, EPR properties, and anti-convulsant activities of binuclear and mononuclear 1,10-phenanthroline and salicylate ternary copper(II) complexes.
    Lemoine P; Viossat B; Morgant G; Greenaway FT; Tomas A; Dung NH; Sorenson JR
    J Inorg Biochem; 2002 Apr; 89(1-2):18-28. PubMed ID: 11931959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, structural analysis and anticonvulsant activity of a ternary Cu(II) mononuclear complex containing 1,10-phenanthroline and the leading antiepileptic drug valproic acid.
    Sylla-Iyarreta Veitía M; Dumas F; Morgant G; Sorenson JR; Frapart Y; Tomas A
    Biochimie; 2009 Oct; 91(10):1286-93. PubMed ID: 19563861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-temperature (180 K) crystal structures of tetrakis-mu-(niflumato)di(aqua)dicopper(II) N,N-dimethylformamide and N,N-dimethylacetamide solvates, their EPR properties, and anticonvulsant activities of these and other ternary binuclear copper(II)niflumate complexes.
    Viossat B; Greenaway FT; Morgant G; Daran JC; Dung NH; Sorenson JR
    J Inorg Biochem; 2005 Feb; 99(2):355-67. PubMed ID: 15621267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Crystallochemistry of copper (II) and zinc (II) chelates by nonsteroidal antiinflammatory drugs].
    Viossat B; Morgant G; Sorenson JR; Roch-Arveiller M; Daran JC; Greenaway FT; Nguyen Huy D
    Ann Pharm Fr; 2002 Mar; 60(2):102-14. PubMed ID: 11976555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticonvulsant activity of p-chlorophenyl substituted arylsemicarbazones--the role of primary terminal amino group.
    Pandeya SN; Mishra V; Ponnilavarasan I; Stables JP
    Pol J Pharmacol; 2000; 52(4):283-90. PubMed ID: 11345484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand oxidations in high-spin nickel thiolate complexes and zinc analogues.
    Chohan BS; Shoner SC; Kovacs JA; Maroney MJ
    Inorg Chem; 2004 Nov; 43(24):7726-34. PubMed ID: 15554637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-anticonvulsant activity studies in the group of (E)-N-cinnamoyl aminoalkanols derivatives monosubstituted in phenyl ring with 4-Cl, 4-CH
    Gunia-Krzyżak A; Żelaszczyk D; Rapacz A; Żesławska E; Waszkielewicz AM; Pańczyk K; Słoczyńska K; Pękala E; Nitek W; Filipek B; Marona H
    Bioorg Med Chem; 2017 Jan; 25(2):471-482. PubMed ID: 27876250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zinc(II) complexes with potent cyclin-dependent kinase inhibitors derived from 6-benzylaminopurine: synthesis, characterization, X-ray structures and biological activity.
    Trávnícek Z; Krystof V; Sipl M
    J Inorg Biochem; 2006 Feb; 100(2):214-25. PubMed ID: 16386795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling substrate- and inhibitor-bound forms of liver alcohol dehydrogenase: chemistry of mononuclear nitrogen/sulfur-ligated zinc alcohol, formamide, and sulfoxide complexes.
    Makowska-Grzyska MM; Jeppson PC; Allred RA; Arif AM; Berreau LM
    Inorg Chem; 2002 Sep; 41(19):4872-87. PubMed ID: 12230391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New mixed ligand zinc(II) complexes based on the antiepileptic drug sodium valproate and bioactive nitrogen-donor ligands. Synthesis, structure and biological properties.
    Darawsheh M; Abu Ali H; Abuhijleh AL; Rappocciolo E; Akkawi M; Jaber S; Maloul S; Hussein Y
    Eur J Med Chem; 2014 Jul; 82():152-63. PubMed ID: 24904962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and anticonvulsant activity of novel 2,6-diketopiperazine derivatives. Part 1: perhydropyrrole[1,2-a]pyrazines.
    Dawidowski M; Herold F; Chodkowski A; Kleps J; Szulczyk P; Wilczek M
    Eur J Med Chem; 2011 Oct; 46(10):4859-69. PubMed ID: 21862182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary evaluation of anticonvulsant activity of some aroxyacetamides and aroxyethylamines.
    Marona H; Waszkielewicz AM; Szneler E
    Acta Pol Pharm; 2005; 62(5):345-53. PubMed ID: 16459483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of 2,6-dicarbethoxy-3,5-diaryltetrahydro-1,4-thiazine-1,1-dioxide derivatives as potent anticonvulsant agents.
    Edayadulla N; Ramesh P
    Eur J Med Chem; 2015 Dec; 106():44-9. PubMed ID: 26519928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and anticonvulsant activity of N-phenylamino derivatives of 3,3-dialkyl-pyrrolidine-2,5-diones and hexahydro-isoindole-1,3-diones.
    Kamiński K; Obniska J
    Bioorg Med Chem; 2008 May; 16(9):4921-31. PubMed ID: 18375131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticonvulsant Activity of Enantiomeric N-trans-Cinnamoyl Derivatives of 2-Aminopropan-1-ols and 2-Aminobutan-1-ols.
    Gunia-Krzyżak A; Żesławska E; Nitek W; Popiół J; Marona H
    Chirality; 2016 Jun; 28(6):482-8. PubMed ID: 27121961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.